Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-125202
Filing Date
2025-12-30
Accepted
2025-12-30 16:00:22
Documents
1
Period of Report
2025-12-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2534508-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2534508-1_4seq1.xml 4 3523
  Complete submission text file 0001104659-25-125202.txt   5092
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EYENOVIA, INC. 23461 SOUTH POINTE DR., SUITE 390 LAGUNA HILLS CA 92653
Business Address
Jung Hyunsu (Reporting) CIK: 0002075658 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 251614155